Astrazeneca To Acquire Neogene Therapeutics, Accelerating Ambition In Oncology Cell Therapy
11/29/22, 7:07 AM
Location
cambridgeNeogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts), today announced it has entered into a definitive agreement to be acquired by AstraZeneca.